Postoperative Radiotherapy
Postoperative Radiotherapy - Related Videos
11:38
Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
0 Views •
Cited by 49 •
2014
The current priority in breast cancer radiotherapy is to reduce cardiac doses without compromising target tissue coverage. The voluntary breath-hold technique described here is a simple, inexpensive solution to this problem and capable of being instituted widely without the need for specialized equipment.
11:24
Stem Cell Transplantation Strategies for the Restoration of Cognitive Dysfunction Caused by Cranial Radiotherapy
0 Views •
Cited by 10 •
2011
Brain tumor patients routinely undergo cranial radiotherapy, and while beneficial, this treatment often results in debilitating cognitive dysfunction. This serious unresolved problem has at present, no clinical recourse, and has driven our efforts to devise stem cell based therapies for the recovery of radiation-induced cognitive decrements.
08:02
Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model
0 Views •
Cited by 9 •
2012
The purpose of this article is to describe the use of an orthotopic glioblastoma model for chemoradiation studies. This article will go though cell processing, implanting, and radiotherapy of the mouse using an intracranial model.
01:32
Pig Surgical Preparation and Postoperative Care
0 Views •
2026
All animal procedures described here must be conducted in accordance with institutional animal ethics guidelines and approved by IACUC. All procedures must follow the principles of the 3Rs—Replacement, Reduction, and Refinement—and must be performed by trained personnel. Surgical Preparation and Physiological Monitoring This video provides an introductory overview of surgical preparation, intraoperative monitoring, and postoperative care in swine. It is intended to familiarize learners with key...
10:10
Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
0 Views •
Cited by 6 •
2011
Cognitive impairment resulting from the radiotherapeutic management of brain tumors represents a clinically intractable condition that adversely impacts quality of life. The capability to critically evaluate potential interventions for ameliorating radiation-induced cognitive decrements ultimately depends on the capability to undertake rigorous quantitative assessments of cognition.
FAQs
Dividing the radiation course into multiple fractions helps manage effects on healthy tissue while maintaining treatment directed at the operative bed or nearby lymphatic regions. This scheduling feature is important when evaluating treatment outcomes because studies may need to consider both the intended reduction in recurrence and the treatment-related toxicity observed during or after therapy.
Recurrence, survival, and treatment-related toxicity provide complementary measures of benefit and harm. Recurrence indicates whether disease returns in the evaluated local or regional setting, survival captures broader patient outcome, and toxicity reflects unwanted treatment effects. Considering these outcomes together prevents an analysis from judging the treatment solely by disease control or solely by adverse effects.
Confounding factors can make outcome differences between patient groups difficult to attribute solely to postoperative radiotherapy. Researchers therefore account for relevant differences when comparing recurrence, survival, or toxicity across groups. This statistical context helps distinguish an apparent treatment association from differences in the patients or clinical settings represented by the comparison.
Treatment may be directed at the operative bed, where microscopic disease could remain after surgery, or at nearby lymphatic regions. These targets connect the treatment plan to the pattern of possible local or regional recurrence. In outcome studies, identifying the treated region is therefore relevant when interpreting recurrence results and comparing clinical settings.
Patients may be observed for different lengths of time, so recurrence and survival results must be interpreted with follow-up time in mind. Statistical analyses account for this timing rather than treating every patient as if observation ended at the same point. Doing so supports more appropriate comparisons of outcomes between groups receiving different treatments or evaluated in different settings.
Researchers compare groups receiving different treatment approaches by examining recurrence, survival, and treatment-related toxicity. These comparisons help clarify whether postoperative radiotherapy changes outcomes in particular clinical settings and support treatment selection. The findings are most informative when analyses also account for follow-up time and confounding factors that could influence observed differences between patient groups.